Left atrial appendage occlusion might be a treatment option for patients on dialysis with atrial fibrillation.
The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...
Using patient-level data from Taiwan's drug-eluting stent (DES) market in the Taipei metropolitan area, we estimate a structural model of hospital behavior, incorporating patient demand and hospitals' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback